HNSN Hansen Medical, Inc. (MM)

Hansen Medical, Inc. (Nasdaq:HNSN) today announced that the underwriters of its initial public offering of 6,250,000 shares have exercised in full their over-allotment option, purchasing an additional 937,500 shares of common stock. Including the over-allotment shares purchased today, the offering totaled 7,187,500 shares of common stock at the public offering price of $12.00 per share, resulting in net proceeds to Hansen Medical of approximately $80.2 million, after underwriters� discounts and commissions. All of the shares in the offering were offered and sold by Hansen Medical. The underwriters of the offering were Morgan Stanley & Co. Incorporated and J.P. Morgan Securities Inc. as joint bookrunners, and Thomas Weisel Partners LLC and Leerink Swann & Co., Inc. as co-managers. A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on November 15, 2006. This offering is being made only by means of a prospectus included in the registration statement. Copies of the final prospectus relating to the offering may be obtained from Morgan Stanley & Co. Incorporated�s prospectus department at 180 Varick, New York, NY 10014, by telephone at (866) 718-1649 or by emailing prospectus@morganstanley.com, or from J.P. Morgan Securities Inc.�s prospectus department at 4 Chase Metrotech Center, Floor L2, Brooklyn, NY 11245 or by telephone at (718) 242-8002. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Hansen Medical, Inc. Hansen Medical, based in Mountain View, Calif., was founded in 2002 to develop products and technology using robotics for the accurate positioning, manipulation and stable control of catheters and catheter-based technologies. The Sensei� Robotic Catheter System and disposable Artisan� Control Catheter are currently under review for FDA clearance to guide catheters for mapping the heart anatomy. Hansen Medical, Inc. (Nasdaq:HNSN) today announced that the underwriters of its initial public offering of 6,250,000 shares have exercised in full their over-allotment option, purchasing an additional 937,500 shares of common stock. Including the over-allotment shares purchased today, the offering totaled 7,187,500 shares of common stock at the public offering price of $12.00 per share, resulting in net proceeds to Hansen Medical of approximately $80.2 million, after underwriters' discounts and commissions. All of the shares in the offering were offered and sold by Hansen Medical. The underwriters of the offering were Morgan Stanley & Co. Incorporated and J.P. Morgan Securities Inc. as joint bookrunners, and Thomas Weisel Partners LLC and Leerink Swann & Co., Inc. as co-managers. A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on November 15, 2006. This offering is being made only by means of a prospectus included in the registration statement. Copies of the final prospectus relating to the offering may be obtained from Morgan Stanley & Co. Incorporated's prospectus department at 180 Varick, New York, NY 10014, by telephone at (866) 718-1649 or by emailing prospectus@morganstanley.com, or from J.P. Morgan Securities Inc.'s prospectus department at 4 Chase Metrotech Center, Floor L2, Brooklyn, NY 11245 or by telephone at (718) 242-8002. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor will there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Hansen Medical, Inc. Hansen Medical, based in Mountain View, Calif., was founded in 2002 to develop products and technology using robotics for the accurate positioning, manipulation and stable control of catheters and catheter-based technologies. The Sensei(TM) Robotic Catheter System and disposable Artisan(TM) Control Catheter are currently under review for FDA clearance to guide catheters for mapping the heart anatomy.